The anti-inflammatory action of most terpenes has been explained in terms of the inhibition of nuclear factor B (NF-B) activity. Ent-kaurene diterpenes are intermediates of the synthesis of gibberellins and inhibit the expression of NO synthase-2 and the release of tumor necrosis factor-␣ in J774 macrophages challenged with lipopolysaccharide. These diterpenes inhibit NF-B and IB kinase (IKK) activation in vivo but failed to affect in vitro the function of NF-B, the phosphorylation and targeting of IB␣, and the activity of IKK-2. Transient expression of NF-B-inducing kinase (NIK) activated the IKK complex and NF-B, a process that was inhibited by kaurenes, indicating that the inhibition of NIK was one of the targets of these diterpenes. These results show that kaurenes impair the inflammatory signaling by inhibiting NIK, a member of the MAPK kinase superfamily that interacts with tumor necrosis factor receptor-associated factors, and mediate the activation of NF-B by these receptors. Moreover, kaurenes delayed the phosphorylation of p38, ERK1, and ERK2 MAPKs, but not that of JNK, in response to lipopolysaccharide treatment of J774 cells. The absence of a coordinate activation of MAPK and IKK might contribute to a deficient activation of NF-B that is involved in the anti-inflammatory activity of these molecules.Activation of the transcription factor NF-B 1 has been shown to be a key component of innate immunity (1), promoting the expression by macrophages of a set of genes involved in host defense, such as pro-inflammatory cytokines (2, 3), NOS-2, cyclooxygenase 2, cell adhesion molecules, and various matrix metalloproteinases (4 -6). NF-B is present constitutively in the cytosol of the cells, where it is retained through the interaction with inhibitory IB proteins that mask the nuclear localization domain of the complex (2). NF-B-dependent gene transcription requires the phosphorylation of IB␣ by IKK2, which releases this inhibitory component from the dimer of Rel proteins (mainly p50, p65, and c-Rel), and is followed by degradation of the phospho-IB by the proteasome (3, 7).Biochemical, pharmacological, and genetic data indicate that the control of NF-B activation constitutes a relevant target for the treatment of inflammatory diseases (2). For this reason, the research on molecules endowed with the capacity to inhibit the consecutive steps leading to NF-B activation has been a subject of current interest (2, 3). In this regard, among the natural products assayed, various terpenoids have been described as potent inhibitors of NF-B activation in response to proinflammatory stimulation. Andalusol, a labdane diterpene from Sideritis exerted anti-inflammatory effects in vivo and in vitro by inhibiting NF-B activation (8, 9). Triterpenes also inhibited NOS-2 expression in RAW 264.7 cells (IC 50 , 0.2-0.3 M) and impaired NF-B activity (10). In the case of sesquiterpenes, it has been described that some of these compounds induce HSP72, which in turn prevents NF-B activation and NOS-2 expression (11, 12).More recently,...